{"url":"https://lda.senate.gov/api/v1/filings/cad2e65a-e1b2-427b-97b8-e3e8a44e5f97/","filing_uuid":"cad2e65a-e1b2-427b-97b8-e3e8a44e5f97","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2014,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cad2e65a-e1b2-427b-97b8-e3e8a44e5f97/print/","filing_document_content_type":"text/html","income":null,"expenses":"170000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Anne Esposito, Vice President, Government Affairs and Public Policy","dt_posted":"2015-01-20T12:54:27.860000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"53 Frontage Road","registrant_address_2":"Third Floor","registrant_different_address":false,"registrant_city":"Hampton","registrant_state":"NJ","registrant_zip":"08827","registrant":{"id":400758262,"url":"https://lda.senate.gov/api/v1/registrants/400758262/","house_registrant_id":null,"name":"IKARIA","description":"Pharmaceutical and medical device research, development and marketing","address_1":"53 Frontage Road","address_2":"Third Floor","address_3":null,"address_4":null,"city":"Hampton","state":"NJ","state_display":"New Jersey","zip":"08827-9001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNE ESPOSITO","contact_telephone":"+1 202-393-7427","dt_updated":"2022-04-06T16:08:09.354786-04:00"},"client":{"id":194966,"url":"https://lda.senate.gov/api/v1/clients/194966/","client_id":12,"name":"IKARIA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57542,"prefix":"ms","prefix_display":"MS.","first_name":"ANNE","nickname":null,"middle_name":"ELIZABETH","last_name":"ESPOSITO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59344,"prefix":"ms","prefix_display":"MS.","first_name":"LEAH","nickname":null,"middle_name":"DUFFY","last_name":"SVOBODA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57542,"prefix":"ms","prefix_display":"MS.","first_name":"ANNE","nickname":null,"middle_name":"ELIZABETH","last_name":"ESPOSITO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59344,"prefix":"ms","prefix_display":"MS.","first_name":"LEAH","nickname":null,"middle_name":"DUFFY","last_name":"SVOBODA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Funding for rare disease research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57542,"prefix":"ms","prefix_display":"MS.","first_name":"ANNE","nickname":null,"middle_name":"ELIZABETH","last_name":"ESPOSITO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59344,"prefix":"ms","prefix_display":"MS.","first_name":"LEAH","nickname":null,"middle_name":"DUFFY","last_name":"SVOBODA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57542,"prefix":"ms","prefix_display":"MS.","first_name":"ANNE","nickname":null,"middle_name":"ELIZABETH","last_name":"ESPOSITO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59344,"prefix":"ms","prefix_display":"MS.","first_name":"LEAH","nickname":null,"middle_name":"DUFFY","last_name":"SVOBODA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}